Patrick J. Crutcher 13D/13G Filings for Avalo Therapeutics, Inc. (AVTX)

Patrick J. Crutcher 13D and 13G filings for Avalo Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-11-07
5:00 pm
Purchase		 2024-09-30 13G Avalo Therapeutics, Inc.
AVTX		 Patrick J. Crutcher 549,467
5.600%		 438,616increase
(+395.68%)		 Filing
2024-08-23
4:05 pm
Purchase		 2024-08-13 13G Avalo Therapeutics, Inc.
AVTX		 Patrick J. Crutcher 110,851
9.900%		 110,851increase
(New Position)		 Filing